Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Trafford
Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All Cause Mortality
Artery Research
Related publications
Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All-Cause Mortality
Heart
Cardiovascular Medicine
Cardiology
Diabetic Ketosis During Hyperglycemic Crisis Is Associated With Decreased All-Cause Mortality in Patients With Type 2 Diabetes Mellitus
Endocrine
Erythropoietin (EPO) Haplotype Associated With All-Cause Mortality in a Cohort of Italian Patients With Type-2 Diabetes
Scientific Reports
Multidisciplinary
Statin Use Reduces Cardiovascular Events and All-Cause Mortality Amongst Chinese Patients With Type 2 Diabetes Mellitus: A 5-Year Cohort Study
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
More Work Is Needed to Better Understand Diabetes Distress as a Predictor of All-Cause Mortality in Type 2 Diabetes
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Target Values of Cardiovascular Risk Factors Are Not Associated With All-Cause Mortality in Patients With Type 2 Diabetes Mellitus
PLoS ONE
Multidisciplinary
All-Cause Mortality and Estimated Renal Function in Type 2 Diabetes Mellitus Outpatients: Is There a Relationship With the Equation Used?
Diabetes and Vascular Disease Research
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Television Viewing and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality
JAMA - Journal of the American Medical Association
Medicine
The Relationship Between Estimated Glomerular Filtration Rate Trajectory and All-Cause Mortality in Type 2 Diabetes: The Fremantle Diabetes Study
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes